The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Mironkov A.B.

GUZ "Gorodskaia klinicheskaia bol'nitsa #12" DZ Moskvy

Priamikov A.D.

Kafedra khirurgii i éndoskopii FUV Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova;
Gorodskaia klinicheskaia bol'nitsa #12, Moskva, Rossiia

Tsvetkov R.S.

Gorodskaia klinicheskaia bol'nitsa #12, Moskva

Abashin M.V.

Kafedra khirurgii i éndoskopii FUV Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova

Cardiogenic shock: current aspects of treatment (literature review)

Authors:

Mironkov A.B., Priamikov A.D., Tsvetkov R.S., Abashin M.V.

More about the authors

Read: 3471 times


To cite this article:

Mironkov AB, Priamikov AD, Tsvetkov RS, Abashin MV. Cardiogenic shock: current aspects of treatment (literature review). Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(1):60‑66. (In Russ.)

Recommended articles:
What we have to change in the treatment of ST-segment elevation myocardial infa­rction?. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):183-190
Endo­vascular treatment and sele­ction criteria for acute mese­nteric ischemia. Piro­gov Russian Journal of Surgery. 2025;(2):13-19

References:

  1. Andrié R.P., Becher U.M., Frommold R. et al. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Crit Care 2012; 16: 4: R152.
  2. Antoniucci D., Valenti R., Migliorini A. et al. Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol 2002; 90: 4: 353-357.
  3. Babaev A., Frederick P.D., Pasta D.J. et al. NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005; 294: 4: 448-454.
  4. Berger P.B., Holmes D.R. Jr., Stebbins A.L. et al. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. Circulation 1997; 96: 1: 122-127.
  5. Bernat I., Abdelaal E., Plourde G. et al. Early and late outcomes after primary percutaneous coronary intervention by radial or femoral approach in patients presenting in acute ST-elevation myocardial infarction and cardiogenic shock. Am Heart J 2013; 165: 3: 338-343.
  6. Beurtheret S., Mordant P., Paoletti X. et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J 2013; 34: 2: 112-120.
  7. Buerke M., Prondzinsky R., Lemm H. et al. Intra-aortic balloon counterpulsation in the treatment of infarction-related cardiogenic shock - review of the current evidence. Artif Organs 2012; 36: 6: 505-511.
  8. Callaway C.W. Induced hypothermia after cardiac arrest improves cardiogenic shock. Crit Care Med 2012; 40: 6: 1963-1964.
  9. Chan A.W., Chew D.P., Bhatt D.L. et al. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2002; 89: 2: 132-136.
  10. de Waha S., Desch S., Eitel I. et al. What is the evidence for IABP in STEMI with and without cardiogenic shock? Ther Adv Cardiovasc Dis 2012; 6: 3: 123-132.
  11. Dzavik V., Sleeper L.A., Cocke T.P. et al. SHOCK Investigators. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 2003; 24: 9: 828-837.
  12. Fornaro G., Prando M.D., Parodi F.et al. Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation. G Ital Cardiol 1996; 26: 12: 1385-1399.
  13. Fox K.A., Steg P.G., Eagle K.A. et al. GRACE Investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007; 297: 17: 1892-1900.
  14. French J.K., Armstrong P.W., Cohen E. et al. Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction". Am Heart J 2011; 162: 1: 89-97.
  15. Fujii T., Masuda N., Ijichi T. et al. Transradial intervention for patients with ST elevation myocardial infarction with or without cardiogenic shock. Catheter Cardiovasc Interv 2013. Feb 25. doi: 10.1002/ccd.24896.
  16. Giri S., Mitchel J., Azar R.R. et al. Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 2002; 89: 2: 126-131.
  17. Götberg M., van der Pals J., Olivecrona G.K. et al. Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model. Resuscitation 2010; 81: 9: 1190-1196.
  18. Hands M.E., Rutherford J.D., Muller J.E. et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol 1989; 14: 1: 40-46; discussion 47-48.
  19. Hasdai D., Harrington R.A., Hochman J.S. et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 2000; 36: 3: 685-692.
  20. Henriques J.P., de Mol B.A. Farewell to the intra-aortic balloon pump? Ned Tijdschr Geneeskd 2013; 157: 11: A5936.
  21. Hochman J.S., Boland J., Sleeper L.A. et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation 1995; 91: 3: 873-881.
  22. Hochman J.S., Sleeper L.A., Webb J.G. et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341: 9: 625-634.
  23. Hochman J.S., Buller C.E., Sleeper L.A. et al. Cardiogenic shock complicating acute myocardial infarction - etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000; 36: 3 Suppl A: 1063-1070.
  24. Hochman J.S., Ohman E.M. Cardiogenic shock. Wiley-Blackwell (USA) 2009.
  25. Holmes D.R. Jr., Bates E.R., Kleiman N.S. et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995; 26: 3: 668-674.
  26. Holmes D.R. Jr, Berger P.B., Hochman J.S. et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999; 100: 20: 2067-2073.
  27. Huang R., Sacks J., Thai H. et al. Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention. Catheter Cardiovasc Interv 2005; 65: 1: 25-33.
  28. Hussain F., Nguyen T., Elmayergi N. et al. The acutely occluded left main coronary artery culprit in cardiogenic shock and initial percutaneous coronary intervention: a substudy of the Manitoba "no option" left main PCI registry. Can J Physiol Pharmacol 2012; 90: 9: 1325-1331.
  29. Jacobs A.K., French J.K., Col J. et al. Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize Occluded coronaries for Cardiogenic shocK? Am Coll Cardiol 2000; 36: 3 Suppl A: 1091-1096.
  30. Killip T., Kimbal J.T. Treatment of myocardial infarction in a coronary care unit a two year experience with 250 patients. Am J Cardiol 1967; 20: 457-464.
  31. Leor J., Goldbourt U., Reicher-Reiss H. et al. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med 1993; 94: 3: 265-273.
  32. Levine G.N., Bates E.R., Blankenship J.C. et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 2012; 79: 3: 453-495.
  33. Mylotte D., Morice M.-C., Eltchaninoff H. et al. Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction, Resuscitated Cardiac Arrest, and Cardiogenic Shock. The Role of Primary Multivessel Revascularization. JACC: Cardiovasc Intervent 2013; 6: 2: 115-125.
  34. Negi S.I., Kar B., Gregoric I. et al. Supporting the failing myocardium: is intra-aortic balloon pump enough? The IABP-SHOCK II trial. Expert Rev Cardiovasc Ther 2013; 11: 2: 147-149.
  35. Ofoma U.R., Ramar K., Kashyap R. Mild therapeutic hypothermia in cardiogenic shock syndrome. Crit Care Med 2013; 41: 2: e14-15.
  36. O'Gara P.T., Kushner F.G., Ascheim D.D. et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2013; 61: 4: e78-140.
  37. Parenica J., Kala P., Jarkovský J. et al. Acute heart failure and early development of left ventricular dysfunction in patients with ST segment elevation acute myocardial infarction managed with primary percutaneous coronary intervention. Vnitr Lek 2011; 57: 1: 43-51.
  38. Porto I., Selvanayagam J.B., Van Gaal W.J. et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 2006; 114: 7: 662-669.
  39. Prondzinsky R., Lemm H., Swyter M. et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010; 38: 1: 152-160.
  40. Prondzinsky R., Unverzagt S., Russ M. et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock 2012; 37: 4: 378-384.
  41. Prondzinsky R., Unverzagt S., Lemm H. et al. Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-&ggr;, TNF-&agr;, MIP-1&Bgr;, G-CSF, and MCP-1&Bgr;. Med Klin Intensiv Med Notfmed 2012; 107: 6: 476-484.
  42. Rodriguez-Leor O., Fernandez-Nofrerias E., Carrillo X. et al. Transradial percutaneous coronary intervention in cardiogenic shock: a single-center experience. Am Heart J 2013; 165: 3: 280-285.
  43. Sanborn T.A., Sleeper L.A., Bates E.R. et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination incardiogenic shock complicating acute myocardial infarction: a report from the SHOCK TrialRegistry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000; 36: 3 Suppl A: 1123-1129.
  44. Sayer G.T., Baker J.N., Parks K.A. Heart rescue: the role of mechanical circulatory support in the management of severe refractory cardiogenic shock. Curr Opin Crit Care 2012; 18: 5: 409-416.
  45. Sgarbossa E.B., Pinski S.L., Topol E.J. et al. Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries. J Am Coll Cardiol 1998; 31: 1: 105-110.
  46. Shawl F.A., Quyyumi A.A., Bajaj S. et al. Percutaneous cardiopulmonary bypass-supported coronary angioplasty in patients with unstable angina pectoris or myocardial infarction and a left ventricular ejection fraction
  47. Sjauw K.D., Engström A.E., Vis M.M. et al. Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock. Neth Heart J 2012; 20: 10: 402-409.
  48. Skulec R., Kovarnik T., Dostalova G. et al. Induction of mild hypothermia in cardiac arrest survivors presenting with cardiogenic shock syndrome. Acta Anaesthesiol Scand 2008; 52: 2: 188-194.
  49. Tang G.H., Malekan R., Kai M. et al. Peripheral venoarterial extracorporeal membrane oxygenation improves survival in myocardial infarction with cardiogenic shock. J Thorac Cardiovasc Surg 2013; 145: 3: e32-e33.
  50. Thiele H., Schuler G., Neumann F.J. et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCKII) trial. Am Heart J 2012; 163: 6: 938-945.
  51. Tousek P., Rokyta R., Tesarova J. et al. Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study. Acute Card Care 2011; 13: 3: 116-122.
  52. Tsao N.W., Shih C.M., Yeh J.S. et al. Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock. J Crit Care 2012; 27: 5: 530.
  53. Urban P., Stauffer J.C., Bleed D. et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-SMASH. Eur Heart J 1999; 20: 14: 1030-1038.
  54. van der Pals J., Götberg M.I., Götberg M. et al. Hypothermia in cardiogenic shock reduces systemic t-PA release. J Thromb Thrombolysis 2011; 32: 1: 72-81.
  55. Vogel R.A., Shawl F., Tommaso C. et al. Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty. J Am Coll Cardiol 1990; 15: 1: 23-29.
  56. Webb J.G., Lowe A.M., Sanborn T.A. et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 2003; 42: 8: 1380-1386.
  57. Werdan K., Ru&Bgr; M., Buerke M. et al. Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch Arztebl Int 2012; 109: 19: 343-351.
  58. White H.D., Assmann S.F., Sanborn T.A. et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation 2005; 112: 13: 1992-2001.
  59. Zeller M., Cottin Y., Brindisi M.C. et al. RICO survey working group. Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction. Eur Heart J 2004; 25: 4: 308-312.
  60. Zeymer U., Vogt A., Zahn R. et al. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Eur Heart J 2004; 25: 4: 322-328.
  61. Zeymer U., Hochadel M., Hauptmann K.E. et al. Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry. Clin Res Cardiol 2013; 102: 3: 223-227.
  62. Zobel C., Adler C., Kranz A. et al. Mild therapeutic hypothermia in cardiogenic shock syndrome. Crit Care Med 2012; 40: 6: 1715-1723.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.